Scientific Reports (Sep 2023)

Label-free drug response evaluation of human derived tumor spheroids using three-dimensional dynamic optical coherence tomography

  • Ibrahim Abd El-Sadek,
  • Larina Tzu-Wei Shen,
  • Tomoko Mori,
  • Shuichi Makita,
  • Pradipta Mukherjee,
  • Antonia Lichtenegger,
  • Satoshi Matsusaka,
  • Yoshiaki Yasuno

DOI
https://doi.org/10.1038/s41598-023-41846-3
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 15

Abstract

Read online

Abstract This study aims at demonstrating label-free drug-response-patterns assessment of different tumor spheroids and drug types by dynamic optical coherence tomography (D-OCT). The study involved human breast cancer (MCF-7) and colon cancer (HT-29) spheroids. The MCF-7 and HT-29 spheroids were treated with paclitaxel (Taxol; PTX) and the active metabolite of irinotecan SN-38, respectively. The drugs were applied with 0 (control), 0.1, 1, and 10 μM concentrations and the treatment durations were 1, 3, and 6 days. A swept-source OCT microscope equipped with a repeated raster scanning protocol was used to scan the spheroids. Logarithmic intensity variance (LIV) and late OCT correlation decay speed (OCDS $$_l$$ l ) algorithms were used to visualize the tumor spheroid dynamics. LIV and OCDS $$_l$$ l images visualized different response patterns of the two types of spheroids. In addition, spheroid morphology, LIV, and OCDS $$_l$$ l quantification showed different time-courses among the spheroid and drug types. These results may indicate different action mechanisms of the drugs. The results showed the feasibility of D-OCT for the evaluation of drug response patterns of different cell spheroids and drug types and suggest that D-OCT can perform anti-cancer drug testing.